Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 25 | TSHA Taysha Gene Therapies | Common Stock | Grant | Acquire A | No | No | 0 | 892,500 | 0.00 | 2,078,358 |
2 Jan 25 | TSHA Taysha Gene Therapies | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.85 | 892,500 | 1.65 mm | 892,500 |
14 May 24 | VTR Ventas | Common Stock | Grant | Acquire A | No | No | 47.96 | 3,648 | 174.96 k | 21,252 |
2 Jan 24 | TSHA Taysha Gene Therapies | Common Stock | Grant | Acquire A | No | No | 0 | 1,184,688 | 0.00 | 1,185,858 |
2 Jan 24 | TSHA Taysha Gene Therapies | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.71 | 1,184,688 | 2.03 mm | 1,184,688 |
14 Dec 23 | TSHA Taysha Gene Therapies | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.6989 | 466,550 | 326.07 k | 466,550 |
16 Aug 23 | TSHA Taysha Gene Therapies | Common Stock | Buy | Acquire P | Yes | No | 0.9 | 444,444 | 400.00 k | 1,535,545 |